To further evaluate expression of Bmi1, its target gene p16INK4a was analyzed in both Bmi1-positive and negative groups with immunohistochemistry, and staining results confirmed Bmi1 status (see ERα-coupled Bmi1 regulatory signature in breast cancer in Results). Here, CDKN2A is linked to breast carcinoma.